Article ; Online: Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNF.
Medical & biological engineering & computing
2017 Volume 55, Issue 12, Page(s) 2069–2077
Abstract: Glial cell line-derived neurotrophic factor (GDNF) is a potential therapy for Parkinson's disease (PD) promoting survival and functional recovery of dopaminergic neurons when delivered to the degenerated striatum. To study the aspects of intraputamenal ... ...
Abstract | Glial cell line-derived neurotrophic factor (GDNF) is a potential therapy for Parkinson's disease (PD) promoting survival and functional recovery of dopaminergic neurons when delivered to the degenerated striatum. To study the aspects of intraputamenal delivery of GDNF, a mathematical model of recombinant methionyl human GDNF (r-metHuGDNF) convection in the human putamen has been developed. The convection-enhanced delivery infusions of r-metHuGDNF were simulated at rates up to 5 μL/min. The high-rate infusions (≥1 μL/min) permit rapid and uniform distribution of drug with up to 75% of the distribution volume having a concentration within 5% of the infusate concentration. No relevant differences in distribution at infusion rates of 3 and 5 μL/min were found. The patterns of GDNF distribution were analyzed in relation to the anatomy of the posterior dorsal putamen, and a cylindrical shape was found to be preferable considering risks of target overflow. A magnetic resonance (MR) tracer Gd-DTPA (Magnevist®) was evaluated as a surrogate in clinical studies, and the most accurate prediction of GDNF distribution was calculated immediately after infusion. The clearance of GDNF from the striatum is confirmed to be slow, with a half-life of ca. 19 h. |
---|---|
MeSH term(s) | Computer Simulation ; Corpus Striatum/diagnostic imaging ; Corpus Striatum/metabolism ; Gadolinium DTPA/administration & dosage ; Gadolinium DTPA/pharmacokinetics ; Glial Cell Line-Derived Neurotrophic Factor/administration & dosage ; Glial Cell Line-Derived Neurotrophic Factor/pharmacokinetics ; Humans ; Models, Biological ; Putamen/diagnostic imaging ; Putamen/metabolism ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/pharmacokinetics |
Chemical Substances | GDNF protein, human ; Glial Cell Line-Derived Neurotrophic Factor ; Recombinant Proteins ; Gadolinium DTPA (K2I13DR72L) |
Language | English |
Publishing date | 2017-12 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 282327-5 |
ISSN | 1741-0444 ; 0025-696X ; 0140-0118 |
ISSN (online) | 1741-0444 |
ISSN | 0025-696X ; 0140-0118 |
DOI | 10.1007/s11517-017-1650-x |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 294: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.